Navigation Links
Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
Date:5/13/2010

Quincy Bioscience announces the launch of HOPETrials.com – a new portal aimed at making research studies of the jellyfish protein apoaequorin accessible for individuals with debilitating conditions. People are encouraged to visit the site to learn about study recruitment. HOPE Trials is the research arm of Quincy Bioscience.

Madison, WI (Vocus) May 13, 2010 -- Quincy Bioscience announces the launch of HOPE Trials.com – a new portal aimed at making research studies of the jellyfish protein apoaequorin accessible for individuals with debilitating conditions. HOPE Trials is the research arm of Quincy Bioscience.


The mission of HOPE Trials is to improve the quality of life for individuals suffering from an array of debilitating conditions such as Alzheimer’s disease and Parkinson’s disease linked by a common cause – a mismanagement of calcium at the cellular level. By bringing research studies into the homes of individuals living with neurodegenerative diseases, researchers are able to achieve larger numbers of participants and improve the quality of data gathered.

Quincy Bioscience research to date has shown the effectiveness of the jellyfish protein apoaequorin to improve cognitive function and other quality of life measures in generally healthy individuals. With the development of the HOPE Trials website and the implementation of clinically-validated rating scales, researchers at Quincy Bioscience will be able to gain better understanding on how this jellyfish protein may help improve the lives of those with neurological conditions.

Mark Underwood, co-founder and president, stresses the importance of both high quality and real world research, “HOPE Trials represents an innovation in research by delivering survey tools directly to participants. Two of the main reasons people choose not to take part in conventional clinical studies are the amount time and travel required. HOPE Trials greatly reduces these demands while gathering important data using the gold standard in research, randomized controlled trials.” explains Underwood.

Maximizing the use of the Internet and social media to help recruitment, HOPE Trials will access a larger demographic of people, and strengthen research. HOPE Trials has begun recruiting for the MS HOPE Trial. Interested parties can visit HOPE Trials.comto find out if they qualify to participate and learn more about future studies.

About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.

###

Read the full story at http://www.prweb.com/releases/hopetrials/research/prweb4001614.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Southridge LLC Provides Equity Capital Through Private Agreement with PuraMed Bioscience
2. Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
4. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
5. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
6. Thriving Bioscience Region Leaves Its Mark
7. Online Candy Store BW Clifford Launches New Candy Lines and Industry News Resources
8. VoIP Supply Launches Video Conferencing Solutions
9. GMARK Launches World's First Web-Like, PowerPoint Navigation Software
10. Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians
11. Capture Medical Billing Launches Facebook Fan Page to Help Improve Medical Billing Issues
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
(Date:1/21/2017)... Viejo, California (PRWEB) , ... January 21, 2017 , ... "ProDOF is the perfect set ... one subject to another subject in a scene," said Christina Austin - CEO of Pixel ... a given scene. Easily create the illusion of a DSLR racking focus from one ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to take an ... of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a ... Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel to cleanse ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... Redwood Family Dermatology has recently joined their multi-specialty medical group. The ... range of cosmetic services. , “We’re excited to add this excellent dermatology practice ...
(Date:1/21/2017)... ... 21, 2017 , ... In the United States, 20 million women and 10 ... they often feel shame for having struggled with an eating disorder as well as ... “Rising Strong in Life After an Eating Disorder” -- to be featured at this ...
(Date:1/20/2017)... ... ... New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift is ... be wheeled out of the way and stored when not in use. It is freestanding ... feedback from customers into specific enhancements and created a new product that is built directly ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Stock-Callers.com today evaluates the following Drug ... Novo Nordisk A/S (NYSE: NVO ), Sucampo Pharmaceuticals ... Inc. (NASDAQ: PTX ). These stocks belong to ... , 2017, finishing near its session lows. As per a ... while shares of health care companies in the S&P 500 ...
(Date:1/20/2017)... 2017 Avillion LLP, a co-developer and financier ... Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg will ... . ... Weinberg has spent more than 17 years as a pharmaceutical and ... micro-cap biotech. Over the course of his career, he has interfaced ...
(Date:1/19/2017)... , Jan. 19, 2017 The U.S. Food ... of Chronic Idiopathic Constipation (CIC) in adult patients. ... chronic gastrointestinal disorders," said Julie Beitz , M.D., director ... Center for Drug Evaluation and Research. "With the availability of ... appropriate treatment for their condition." ...
Breaking Medicine Technology: